Hui D Y, Brecht W J, Hall E A, Friedman G, Innerarity T L, Mahley R W
J Biol Chem. 1986 Mar 25;261(9):4256-67.
Previous results have demonstrated that liver membranes possess two distinct lipoprotein receptors: a low density lipoprotein (LDL) receptor that binds lipoproteins containing either apolipoprotein (apo-) B or apo-E, and an apo-E-specific receptor that binds apo-E-containing lipoproteins, but not the apo-B-containing LDL. This study reports the isolation and purification of apo-B,E(LDL) and apo-E receptors from canine and human liver membranes. The receptors were solubilized with the zwitterionic detergent 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate and were partially purified by DEAE-cellulose chromatography. The apo-B,E(LDL) receptor was isolated by affinity chromatography on LDL-Sepharose. The apo-E receptor, which did not bind to the LDL-Sepharose column, was then purified by using an HDLc (cholesterol-induced high density lipoprotein)-Sepharose affinity column and an immunoaffinity column. Characterization of the receptors revealed that the hepatic apo-B,E(LDL) receptor is similar to the extrahepatic LDL receptor with an apparent Mr = 130,000 on non-reducing sodium dodecyl sulfate-polyacrylamide gels. The apo-E receptor was found to be distinct from the apo-B,E(LDL) receptor, with an apparent Mr = 56,000. The purified apo-E receptor displayed Ca2+-dependent binding to apo-E-containing lipoproteins and did not bind to LDL or chemically modified apo-E HDLc. Antibodies raised against the apo-B,E(LDL) receptor cross-reacted with the apo-E receptor. However, an antibody prepared against the apo-E receptor did not react with the apo-B,E(LDL) receptor. The apo-E receptor also differed from the apo-B,E(LDL) receptor in amino acid composition, indicating that the apo-E receptor and the apo-B,E(LDL) receptor are two distinct proteins. Immunoblot characterization with anti-apo-E receptor immunoglobulin G indicated that the apo-E receptor is present in the hepatic membranes of man, dogs, rats, and mice and is localized to the rat liver parenchymal cells.
先前的研究结果表明,肝细胞膜具有两种不同的脂蛋白受体:一种低密度脂蛋白(LDL)受体,可结合含有载脂蛋白(apo-)B或apo-E的脂蛋白;另一种是apo-E特异性受体,可结合含apo-E的脂蛋白,但不结合含apo-B的LDL。本研究报告了从犬类和人类肝细胞膜中分离和纯化apo-B、E(LDL)受体和apo-E受体的过程。用两性离子去污剂3-[(3-胆酰胺丙基)-二甲基铵]-1-丙烷磺酸盐使受体溶解,并通过DEAE-纤维素色谱法进行部分纯化。apo-B、E(LDL)受体通过在LDL-琼脂糖上的亲和色谱法分离。不与LDL-琼脂糖柱结合的apo-E受体,随后通过使用HDLc(胆固醇诱导的高密度脂蛋白)-琼脂糖亲和柱和免疫亲和柱进行纯化。对受体的表征显示,肝apo-B、E(LDL)受体与肝外LDL受体相似,在非还原十二烷基硫酸钠-聚丙烯酰胺凝胶上的表观分子量为130,000。发现apo-E受体与apo-B、E(LDL)受体不同,表观分子量为56,000。纯化的apo-E受体显示出对含apo-E脂蛋白的Ca2+依赖性结合,不与LDL或化学修饰的apo-E HDLc结合。针对apo-B、E(LDL)受体产生的抗体与apo-E受体发生交叉反应。然而,针对apo-E受体制备的抗体不与apo-B、E(LDL)受体反应。apo-E受体在氨基酸组成上也与apo-B、E(LDL)受体不同,表明apo-E受体和apo-B、E(LDL)受体是两种不同的蛋白质。用抗apo-E受体免疫球蛋白G进行的免疫印迹表征表明,apo-E受体存在于人类、犬类、大鼠和小鼠的肝细胞膜中,并定位于大鼠肝实质细胞。